Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Jaehyeon Hwang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Maleates, Virus Inactivation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Samsung, Korea Health Industry Development Institute, Sungkyunkwan University.
Abstract (Originalsprache)
Respiratory viruses, such as influenza A virus and SARS-CoV-2, continue to pose significant global health challenges. Current antivirals, which are often specific to a single virus, face limitations due to rapid mutations and the emergence of new strains. In this study, we introduce styrene maleic acid copolymer lipid particle nanodiscs (SMALP-NDs) as a broad-spectrum antiviral platform that employs a dual mode of action. First, SMALP-NDs bind to positively charged viral proteins via their negatively charged surfaces, thereby blocking viral entry. Second, they induce the collapse of viral envelopes under acidic conditions similar to those in the endosome, leading to virus inactivation via a cell-mediated mechanism. SMALP-NDs demonstrated broad-spectrum antiviral activity against influenza A/B and multiple SARS-CoV-2 variants, including Omicron JN.1, as well as herpes simplex virus types 1 and 2 and vaccinia virus, underscoring their versatility. Intranasal administration of SMALP-NDs has successfully protected mice from lethal H1N1 and H5N2 influenza A viruses as well as SARS-CoV-2. These findings underscore that SMALP-NDs effectively counteract the increasing positive charge of emerging viral proteins through their negatively charged surfaces while leveraging pH-responsive virus inactivation mechanisms to achieve high antiviral efficacy with low toxicity, offering a significant advantage over traditional antiviral nanomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 28644, Republic of Korea.
- Research Center, Mvrix, Inc., Anyang 14058, Republic of Korea.
ORCID-Profile: Younghun Jung, Woo-Jae Chung, Dae-Hyuk Kweon
Förderung
- Samsung
- Korea Health Industry Development Institute
- Sungkyunkwan University
- National Research Foundation of Korea
Zitieren
APA
Hwang, J., Kim, M., Jung, Y., Kim, S., Kim, B. K., Choi, S., Park, W., Oh, H., Moon, J., Yoon, J. H., Kim, S., Kim, H., Choo, H., Park, E., Kim, M. K., Moon, S., Yu, S., Jung, S., Song, M. S., …, & Kweon, D. H. (2025). Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00037
Vancouver
Hwang J, Kim M, Jung Y, Kim S, Kim BK, Choi S, et al. Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00037
BibTeX
@article{Hwang2025,
author = {Hwang, Jaehyeon and Kim, Misoo and Jung, Younghun and Kim, Soomin and Kim, Beom Kyu and Choi, Soyun and Park, Wonbeom and Oh, Hyunseok and Moon, Jeonghui and Yoon, Jeong Hyeon and Kim, Suhyun and Kim, Hwanju and Choo, Hyunjoo and Park, EunKhang and Kim, Min Kyeom and Moon, Seokoh and Yu, Seokhyeon and Jung, Sangwon and Song, Min-Suk and Chung, Woo-Jae and Kweon, Dae-Hyuk},
title = {Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00037}
}
EUVIMED